Herbert Wachtel heads Boehringer Ingelheim’s Respiratory Technology Laboratory and reads Pharmaceutical Technology at the Johannes Gutenberg University of Mainz, Germany. During the past 27 years, Herbert has contributed to BI’s Inhaler Development in general and now supports BI microParts, the home of Respimat®. His current interest is in combination product development with inhalers being challenging examples of medical devices.
